results for "" found.

  • Precision Medicine and Liquid Biopsy Program

    This project seeks to cure canine hemangiosarcoma through a combination of advanced diagnostics, personalized medicine, and cancer genomics.

    Visit Page
  • About Us

    One hundred percent of the Organization’s time is allocated to the achievement of the Organization’s tax-exempt purpose.

    Visit Page
  • Hemangiosarcoma Program

    Our Programs and Priorities Hemangiosarcoma (HSA) is an aggressive cancer in dogs and carries a poor prognosis. There are limited therapeutic options for the treatment of HSA, with none currently…

    Visit Page
  • Novel Therapeutics Program

    Our Programs and Priorities Therapeutic development is often a complex, costly, and risky undertaking. Ethos Discovery in collaboration with the Ethos Compounding Pharmacy have a unique opportunity to de-risk the…

    Visit Page
  • Intestinal Dysbiosis Program

    Our Programs and Priorities Intestinal dysbiosis is an alteration in the composition and/or richness of the normal bacteria that are found in the gastrointestinal tract (microbiota). It has been suggested…

    Visit Page
  • Philanthropic Strategy

    Ethos Discovery uses donations and in-kind support from Ethos Veterinary Health, to initiate and launch new scientific projects.

    Visit Page
  • Opportunities For Giving

    Our administrative costs are fully funded! This means 100% of your gift supports medical research

    Visit Page
  • Inflammatory CNS Disease Program

    Our Programs and Priorities Necrotizing meningoencephalitis (NME) in pugs is a severe neurological disease that is typically progressive and often only manifests as overt clinical symptoms after significant damage to…

    Visit Page
  • Sepsis Program

    Our Programs and Priorities Sepsis is the result of a severe infection and has a high mortality rate. Even though sepsis has been heavily researched over the last number of…

    Visit Page
  • Ambassador Program

    Visit Page
  • Home

    Visit Page
  • FAQs

    Visit Page
  • Load More